Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Second generation virus-like particles (VLP) from Epstein-Barr viruses for vaccination purposes

Second generation virus-like particles (VLP) from Epstein-Barr viruses for vaccination purposes

US Patent 9517261 · Granted Dec 13, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Epstein-Barr virus-like particles with broadened antigenic spectrum2023
Anti-CD73 monoclonal antibody, encoding nucleic acids and method for producing2022
Tissue-specific exosomes as biomarkers2021
EBV vaccine2021
B-cell receptor complex binding proteins containing T-cell epitopes2021
B-cell receptor complex binding proteins containing T-cell epitopes2021
B-cell receptor complex binding proteins containing T-cell epitopes2018
B-cell receptor complex binding proteins containing T-cell epitopes2018
Ex vivo method for producing a preparation containing CD4+ T cells specific for 2015
Ex vivo method for producing a preparation containing CD4+ T cells specific for 2015
Method for helper virus-free packaging of a gene vector DNA2002
DNA virus vectors and methods for their preparation2001